Ligand profile
ZINC507388719
Virtual-screening candidate from ZINC.
Bound to: VK055_2471 — UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosaminedeacetylase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC507388719- UniProt (similar protein)
P0A725- Tanimoto
- 0.688
- Target protein
- VK055_2471
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 75.3
- −1 ≤ LogP ≤ 5 4.37
- MW ≤ 500 Da 430.5
- LogP ≤ 5 4.37
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 75.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(Nc1ccccc1)[C@H](Cc1ccccc1)NS(=O)(=O)c1ccc2ccccc2c1O=C(Nc1ccccc1)[C@H](Cc1ccccc1)NS(=O)(=O)c1ccc2ccccc2c1
InChI=1S/C25H22N2O3S/c28-25(26-22-13-5-2-6-14-22)24(17-19-9-3-1-4-10-19)27-31(29,30)23-16-15-20-11-7-8-12-21(20)18-23/h1-16,18,24,27H,17H2,(H,26,28)/t24-/m0/s1InChI=1S/C25H22N2O3S/c28-25(26-22-13-5-2-6-14-22)24(17-19-9-3-1-4-10-19)27-31(29,30)23-16-15-20-11-7-8-12-21(20)18-23/h1-16,18,24,27H,17H2,(H,26,28)/t24-/m0/s1
XWWZYVNGSNVMNX-DEOSSOPVSA-NXWWZYVNGSNVMNX-DEOSSOPVSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL261713
- Homolog
- P0A725
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC507388719 →
- ZINC ZINC20 ZINC507388719 →
- UniProt UniProt P0A725 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC507388719”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2471.
PDB 41
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).